[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Immuno-Oncology Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: I69E612A10C6EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Immuno-Oncology Treatment in Global, including the following market information:

Global Immuno-Oncology Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Immuno-Oncology Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immune Checkpoint Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immuno-Oncology Treatment include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno-Oncology Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immuno-Oncology Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Immuno-Oncology Treatment Market Segment Percentages, by Type, 2021 (%)
  • Immune Checkpoint Inhibitors
  • Monoclonal Antibodies
  • Cytokine-Based Immunotherapy
  • Cancer Vaccines
  • CAR-T Cell Therapy
Global Immuno-Oncology Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Immuno-Oncology Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospitals
  • Ambulatory Surgical Center
  • Others
Global Immuno-Oncology Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Immuno-Oncology Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immuno-Oncology Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Immuno-Oncology Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli-Lilly
  • Roche
  • GlaxoSmithKline
  • Janssen Biotech
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • Spectrum Pharmaceuticals
  • Takeda
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immuno-Oncology Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immuno-Oncology Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNO-ONCOLOGY TREATMENT OVERALL MARKET SIZE

2.1 Global Immuno-Oncology Treatment Market Size: 2021 VS 2028
2.2 Global Immuno-Oncology Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Immuno-Oncology Treatment Players in Global Market
3.2 Top Global Immuno-Oncology Treatment Companies Ranked by Revenue
3.3 Global Immuno-Oncology Treatment Revenue by Companies
3.4 Top 3 and Top 5 Immuno-Oncology Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Immuno-Oncology Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-Oncology Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Immuno-Oncology Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Immuno-Oncology Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Immuno-Oncology Treatment Market Size Markets, 2021 & 2028
  4.1.2 Immune Checkpoint Inhibitors
  4.1.3 Monoclonal Antibodies
  4.1.4 Cytokine-Based Immunotherapy
  4.1.5 Cancer Vaccines
  4.1.6 CAR-T Cell Therapy
4.2 By Type - Global Immuno-Oncology Treatment Revenue & Forecasts
  4.2.1 By Type - Global Immuno-Oncology Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Immuno-Oncology Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Immuno-Oncology Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immuno-Oncology Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Center
  5.1.4 Others
5.2 By Application - Global Immuno-Oncology Treatment Revenue & Forecasts
  5.2.1 By Application - Global Immuno-Oncology Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Immuno-Oncology Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Immuno-Oncology Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Immuno-Oncology Treatment Market Size, 2021 & 2028
6.2 By Region - Global Immuno-Oncology Treatment Revenue & Forecasts
  6.2.1 By Region - Global Immuno-Oncology Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Immuno-Oncology Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Immuno-Oncology Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Immuno-Oncology Treatment Revenue, 2017-2028
  6.3.2 US Immuno-Oncology Treatment Market Size, 2017-2028
  6.3.3 Canada Immuno-Oncology Treatment Market Size, 2017-2028
  6.3.4 Mexico Immuno-Oncology Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Immuno-Oncology Treatment Revenue, 2017-2028
  6.4.2 Germany Immuno-Oncology Treatment Market Size, 2017-2028
  6.4.3 France Immuno-Oncology Treatment Market Size, 2017-2028
  6.4.4 U.K. Immuno-Oncology Treatment Market Size, 2017-2028
  6.4.5 Italy Immuno-Oncology Treatment Market Size, 2017-2028
  6.4.6 Russia Immuno-Oncology Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Immuno-Oncology Treatment Market Size, 2017-2028
  6.4.8 Benelux Immuno-Oncology Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Immuno-Oncology Treatment Revenue, 2017-2028
  6.5.2 China Immuno-Oncology Treatment Market Size, 2017-2028
  6.5.3 Japan Immuno-Oncology Treatment Market Size, 2017-2028
  6.5.4 South Korea Immuno-Oncology Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Immuno-Oncology Treatment Market Size, 2017-2028
  6.5.6 India Immuno-Oncology Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Immuno-Oncology Treatment Revenue, 2017-2028
  6.6.2 Brazil Immuno-Oncology Treatment Market Size, 2017-2028
  6.6.3 Argentina Immuno-Oncology Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Immuno-Oncology Treatment Revenue, 2017-2028
  6.7.2 Turkey Immuno-Oncology Treatment Market Size, 2017-2028
  6.7.3 Israel Immuno-Oncology Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Immuno-Oncology Treatment Market Size, 2017-2028
  6.7.5 UAE Immuno-Oncology Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Immuno-Oncology Treatment Major Product Offerings
  7.1.4 Amgen Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.1.5 Amgen Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Immuno-Oncology Treatment Major Product Offerings
  7.2.4 AstraZeneca Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Eli-Lilly
  7.4.1 Eli-Lilly Corporate Summary
  7.4.2 Eli-Lilly Business Overview
  7.4.3 Eli-Lilly Immuno-Oncology Treatment Major Product Offerings
  7.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.4.5 Eli-Lilly Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Immuno-Oncology Treatment Major Product Offerings
  7.5.4 Roche Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Immuno-Oncology Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Janssen Biotech
  7.7.1 Janssen Biotech Corporate Summary
  7.7.2 Janssen Biotech Business Overview
  7.7.3 Janssen Biotech Immuno-Oncology Treatment Major Product Offerings
  7.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.7.5 Janssen Biotech Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Immuno-Oncology Treatment Major Product Offerings
  7.8.4 Merck Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News
7.9 Novartis
  7.9.1 Novartis Corporate Summary
  7.9.2 Novartis Business Overview
  7.9.3 Novartis Immuno-Oncology Treatment Major Product Offerings
  7.9.4 Novartis Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.9.5 Novartis Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Immuno-Oncology Treatment Major Product Offerings
  7.10.4 Pfizer Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Immuno-Oncology Treatment Major Product Offerings
  7.11.4 Sanofi Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News
7.12 Spectrum Pharmaceuticals
  7.12.1 Spectrum Pharmaceuticals Corporate Summary
  7.12.2 Spectrum Pharmaceuticals Business Overview
  7.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Major Product Offerings
  7.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.12.5 Spectrum Pharmaceuticals Key News
7.13 Takeda
  7.13.1 Takeda Corporate Summary
  7.13.2 Takeda Business Overview
  7.13.3 Takeda Immuno-Oncology Treatment Major Product Offerings
  7.13.4 Takeda Immuno-Oncology Treatment Revenue in Global Market (2017-2022)
  7.13.5 Takeda Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Immuno-Oncology Treatment Market Opportunities & Trends in Global Market
Table 2. Immuno-Oncology Treatment Market Drivers in Global Market
Table 3. Immuno-Oncology Treatment Market Restraints in Global Market
Table 4. Key Players of Immuno-Oncology Treatment in Global Market
Table 5. Top Immuno-Oncology Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Immuno-Oncology Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Immuno-Oncology Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Immuno-Oncology Treatment Product Type
Table 9. List of Global Tier 1 Immuno-Oncology Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-Oncology Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immuno-Oncology Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Immuno-Oncology Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Immuno-Oncology Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Immuno-Oncology Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Immuno-Oncology Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Immuno-Oncology Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Immuno-Oncology Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Immuno-Oncology Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Immuno-Oncology Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Immuno-Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Immuno-Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Immuno-Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Immuno-Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Immuno-Oncology Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Immuno-Oncology Treatment Product Offerings
Table 32. Amgen Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Immuno-Oncology Treatment Product Offerings
Table 35. AstraZeneca Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Immuno-Oncology Treatment Product Offerings
Table 38. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Eli-Lilly Corporate Summary
Table 40. Eli-Lilly Immuno-Oncology Treatment Product Offerings
Table 41. Eli-Lilly Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Immuno-Oncology Treatment Product Offerings
Table 44. Roche Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Immuno-Oncology Treatment Product Offerings
Table 47. GlaxoSmithKline Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Janssen Biotech Corporate Summary
Table 49. Janssen Biotech Immuno-Oncology Treatment Product Offerings
Table 50. Janssen Biotech Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Immuno-Oncology Treatment Product Offerings
Table 53. Merck Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Novartis Corporate Summary
Table 55. Novartis Immuno-Oncology Treatment Product Offerings
Table 56. Novartis Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Immuno-Oncology Treatment Product Offerings
Table 59. Pfizer Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Immuno-Oncology Treatment Product Offerings
Table 62. Sanofi Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Spectrum Pharmaceuticals Corporate Summary
Table 64. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Offerings
Table 65. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Takeda Corporate Summary
Table 67. Takeda Immuno-Oncology Treatment Product Offerings
Table 68. Takeda Immuno-Oncology Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Immuno-Oncology Treatment Segment by Type in 2021
Figure 2. Immuno-Oncology Treatment Segment by Application in 2021
Figure 3. Global Immuno-Oncology Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immuno-Oncology Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immuno-Oncology Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2021
Figure 8. By Type - Global Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 12. US Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 24. China Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Immuno-Oncology Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Immuno-Oncology Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli-Lilly Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Janssen Biotech Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Takeda Immuno-Oncology Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications